The BRAFV600E mutation analysis and risk stratification in papillary thyroid carcinoma

Autor: Ana Patrícia de Cristo, José Miguel Dora, André Borsatto Zanella, Rafael Selbach Scheffel, Lucieli Ceolin, Mirian Romitti, Ana Luiza Maia, Carla Vaz Ferreira Vargas

Publikováno v: Archives of Endocrinology and Metabolism, Vol 64, Iss 6, Pp 751-757 (2020)
Archives of Endocrinology and Metabolism, Volume: 64, Issue: 6, Pages: 751-757, Published: 28 AUG 2020
Archives of Endocrinology and Metabolism, Issue: ahead, Published: 28 AUG 2020
Archives of Endocrinology and Metabolism, 64 (6
Archives of Endocrinology and Metabolism v.64 n.6 2020
Arquivos de Endocrinologia e Metabolismo
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM

Objective: Although the prognostic role of BRAFV600E mutation in papillary thyroid carcinoma (PTC) is controversial, the American Thyroid Association (ATA) includes the mutational status in their risk stratification system. To evaluate the impact of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5231339922357a8c23553da715e87d0f
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972020000600751&tlng=en

The tissue expression pattern of CA 19.9 is associated with oncological features in medullary thyroid carcinoma

Autor: Rafael Selbach Scheffel, Lucieli Ceolin, Antônio Felippe Benini, Carla Vaz Ferreira Vargas, Ana Luiza Maia, Márcia Silveira Graudenz

Publikováno v: Endocrine. 70(3)

Elevated serum levels of carbohydrate antigen 19.9 (CA19.9), a well-established tumor marker in pancreatic neoplasms, has been proposed as a prognostic marker of tumor aggressiveness in medullary thyroid carcinoma (MTC). A hypothesis of C-cell dediff

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c629a1f9ee21b0db22524f042f050fd6
https://pubmed.ncbi.nlm.nih.gov/32535684

Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study

Autor: Mariola Pęczkowska, Akihiro Sukurai, Anita Špehar Uroić, Andreas Machens, Laura Fugazzola, Tushar Bandgar, Carla Vaz Ferreira Vargas, Hartmut P. H. Neumann, Martin Schlumberger, Delphine Drui, Patricia Fainstein-Day, Francoise Borson Chazot, Amandine Berdelou, Tom R. Kurzawinski, Delphine Mirebeau-Prunier, Olivier Chabre, Dominique Maiter, Philippe Caron, Gabriella Sanso, Tsuneo Imai, Camilo Jimenez, Frederic Sebag, Márta Korbonits, Atila Patocs, Laura Valerio, Sarka Dvorakova, Claudio Letizia, Srivandana Akshintala, Christian Godballe, Regis Cohen, Eric Baudin, Caterina Mian, Jolanta Krajewska, Rossella Elisei, Laurence Leclerc, Tobias Else, Marc Klein, Kornelia Hasse-Lazar, Thierry Brue, Steven G. Waguespack, Petr Vlcek, Nuria Valdes, Thera P. Links, Ana Luisa Maia, Ana O. Hoff, Henning Dralle, Frederic Castinetti, André Lacroix, Xiao Ping Qi, Maria João Bugalho, Maralyn Druce, Nelson Wohllk, Barbara Jarzab, Birke Bausch, Delmar M. Lourenço, John Glod, Shinya Uchino, Caroline Brain, Letizia Canu, Charis Eng, Marta Barontini, Jes Sloth Mathiesen, Antoine Tabarin, Elizabeth G. Grubbs, Lucieli Ceolin, Sandrine Laboureau

Publikováno v: The Lancet Diabetes and Endocrinology
The Lancet Diabetes and Endocrinology, 2019, 7 (3), pp.213-220. ⟨10.1016/S2213-8587(18)30336-X⟩
Castinetti, F, Waguespack, S G, Machens, A, Uchino, S, Lazaar, K, Sanso, G, Else, T, Dvorakova, S, Qi, X P, Elisei, R, Maia, A L, Glod, J, Lourenço, D M, Valdes, N, Mathiesen, J, Wohllk, N, Bandgar, T R, Drui, D, Korbonits, M, Druce, M R, Brain, C, Kurzawinski, T, Patocs, A, Bugalho, M J, Lacroix, A, Caron, P, Fainstein-Day, P, Borson Chazot, F, Klein, M, Links, T P, Letizia, C, Fugazzola, L, Chabre, O, Canu, L, Cohen, R, Tabarin, A, Spehar Uroic, A, Maiter, D, Laboureau, S, Mian, C, Peczkowska, M, Sebag, F, Brue, T, Mirebeau-Prunier, D, Leclerc, L, Bausch, B, Berdelou, A, Sukurai, A, Vlcek, P, Krajewska, J, Barontini, M, Vaz Ferreira Vargas, C, Valerio, L, Ceolin, L, Akshintala, S, Hoff, A, Godballe, C, Jarzab, B, Jimenez, C, Eng, C, Imai, T, Schlumberger, M, Grubbs, E, Dralle, H, Neumann, H P & Baudin, E 2019, ' Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B : an international, multicentre, retrospective study ', The Lancet Diabetes & Endocrinology, vol. 7, no. 3, pp. 213-220 . https://doi.org/10.1016/S2213-8587(18)30336-X
The Lancet. Diabetes & Endocrinology
The Lancet. Diabetes & Endocrinology, 2019, 7 (3), pp.213-220. ⟨10.1016/S2213-8587(18)30336-X⟩
Lancet Diabetes & Endocrinology, 7(3), 213-220. ELSEVIER SCIENCE INC

© 2019 Elsevier Ltd. All rights reserved.
Background: Multiple endocrine neoplasia type 2B is a rare syndrome caused mainly by Met918Thr germline RET mutation, and characterised by medullary thyroid carcinoma, phaeochromocytoma, and extra-endoc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb4c67f529d8d0b7cbd0f6301632ecc3
https://hdl.handle.net/10451/54220